Expert Interview

This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

A Look at the Skylark study and discussing Zuranolone in postpartum depression (PPD)

Ticker(s): SAGE, BIIB

Who's the expert?

- Manages about 5-7 patients with PPD per month
- Has read the and could discuss the Skylark study for Zuranolone (SAGE-217) in PPD

Interview Goal

Discussing Zuranolone in postpartum depression (PPD) after Skylark study: Currently approved for IV but this was oral. Generic name = (SAGE-217/BIIB125)

Do you want answers to these questions?

Yes! Sign me up for FREE
so I can learn more Yes.
LOGIN!

Click Here to Access
This Project

Slingshot Insights Explained

JOIN FOR FREE TODAY

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

Click Here to Access
This Project

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.